Ichor Vascular, Inc. is a medical device company developing advanced arterial and venous solutions to bridge clinical gaps in thrombectomy technologies. Headquartered in Boca Raton, Florida, the firm innovates surgical tools for vascular treatments.
Subscribe to see ICHOR VASCULAR, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ICHOR VASCULAR, INC. is a healthcare company headquartered in United States. It has raised at least $3.1M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series A, closed in May 2026. Xcout tracks 7 named people at ICHOR VASCULAR, INC., including Timothy Blair (CHIEF EXECUTIVE OFFICER).
1 more named person on record for ICHOR VASCULAR, INC., with roles, board committees and tenure — see the full roster →
At least $3.1M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | — | |
| Series A | $2.9M | — | |
| SEC Form D filing | $202,499 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ICHOR VASCULAR, INC.'s closest competitors — see the full list of competitors and alternatives →
Innoventric is a medical device company founded in 2016 and headquartered in Rehovot, Israel, dedicated to addressing the complexities of tricuspid regurgitation with transcatheter solutions.
Aurora Medical Technologies is a medical equipment manufacturing company based in the United States developing platforms to revolutionize surgical suturing and endoscopic surgery.
VESTECK, Inc. is a medical device company founded in 2019 and headquartered in West Chester, Pennsylvania. The company specializes in endovascular repair technologies, notably developing the 'SUTURE-TIGHT' catheter system.
Ablative Solutions, Inc. is a medical device company headquartered in San Jose, California. Founded to address unmet clinical needs in the treatment of hypertension, the company develops interventional therapeutic devices.
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Shanghai HeartCare Medical Technology Corporation Limited is a global enterprise specializing in the research, development, manufacturing, and commercialization of neuro-interventional medical devices. Its extensive product range encompasses devices for ischemic stroke thrombectomy, intracranial stenosis intervention, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access. These medical technologies are utilized for both the prevention and treatment of ischemic stroke, including acute ischemic events and intracranial narrowing, as well as for addressing hemorrhagic stroke. Established in 2016 and previously operating as Shanghai Care Medical Technology Corporation Limited, the company maintains its headquarters in Shanghai, People's Republic of China.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.